A cytomegalovirus glycoprotein re‐routes MHC class I complexes to lysosomes for degradation
暂无分享,去创建一个
U. Koszinowski | P. Lučin | W. Muranyi | H. Hengel | U. Reusch | H. Burgert
[1] B. Hoflack,et al. Mechanisms of protein sorting and coat assembly: insights from the clathrin-coated vesicle pathway. , 1998, Current opinion in cell biology.
[2] U. Koszinowski,et al. Immune evasion by cytomegalovirus--survival strategies of a highly adapted opportunist. , 1998, Trends in microbiology.
[3] F. Brodsky,et al. Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. , 1998, Immunity.
[4] K. von Figura,et al. A di‐leucine‐based motif in the cytoplasmic tail of LIMP‐II and tyrosinase mediates selective binding of AP‐3 , 1998, The EMBO journal.
[5] C. Geisler,et al. Regulation and Function of the CD3γ DxxxLL Motif: A Binding Site for Adaptor Protein-1 and Adaptor Protein-2 in Vitro , 1997, The Journal of cell biology.
[6] A. McMichael,et al. Evasion of Cytotoxic T Lymphocyte (CTL) Responses by Nef-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus–infected Cells , 1997, The Journal of experimental medicine.
[7] P. Cresswell,et al. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[8] U. Koszinowski,et al. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. , 1997, Immunity.
[9] P. A. Peterson,et al. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.
[10] P. Cresswell,et al. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[11] H. Ploegh,et al. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface , 1997, The EMBO journal.
[12] J. Skowroński,et al. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling , 1997, The EMBO journal.
[13] T. Rapoport,et al. Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction , 1996, Nature.
[14] B. Barrell,et al. Analysis of the complete DNA sequence of murine cytomegalovirus , 1996, Journal of virology.
[15] H. Ploegh,et al. Intermediates in the Assembly and Degradation of Class I Major Histocompatibility Complex (MHC) Molecules Probed with Free Heavy Chain–specific Monoclonal Antibodies , 1996, The Journal of experimental medicine.
[16] K. Smith,et al. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove. , 1996, Journal of immunology.
[17] H. Ploegh,et al. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] P. A. Peterson,et al. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Bogyo,et al. The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol , 1996, Cell.
[20] F. Lemonnier,et al. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein , 1996, Nature Medicine.
[21] G. Geginat,et al. Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport , 1995, Journal of virology.
[22] M. Jackson,et al. A Role for Acidic Residues in Di-leucine Motif-based Targeting to the Endocytic Pathway (*) , 1995, The Journal of Biological Chemistry.
[23] J. Yewdell,et al. Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.
[24] P. A. Peterson,et al. A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.
[25] N. Saijo,et al. Construction of a novel bovine papillomavirus vector without detectable transforming activity suitable for gene transfer. , 1995, Human gene therapy.
[26] M. Sugita,et al. Association of the Invariant Chain with Major Histocompatibility Complex Class I Molecules Directs Trafficking to Endocytic Compartments (*) , 1995, The Journal of Biological Chemistry.
[27] U. Koszinowski,et al. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor , 1994, Journal of virology.
[28] O. Bakke,et al. Targeting of membrane proteins to endosomes and lysosomes. , 1994, Trends in Cell Biology.
[29] M. J. Clague,et al. Vacuolar ATPase activity is required for endosomal carrier vesicle formation. , 1994, The Journal of biological chemistry.
[30] U. Koszinowski,et al. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment , 1992, The Journal of experimental medicine.
[31] U. Koszinowski,et al. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.
[32] O. Bakke,et al. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.
[33] U. Koszinowski,et al. Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase , 1989, Cell.
[34] J. Strominger,et al. Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[35] E. Yunis,et al. Receptor-like nature of class I HLA: endocytosis via coated pits. , 1988, Journal of immunology.
[36] S. Hoffstein,et al. Major histocompatibility complex class I molecules internalized via coated pits in T lymphocytes , 1987, Nature.
[37] U. Koszinowski,et al. The 89,000-Mr murine cytomegalovirus immediate-early protein activates gene transcription , 1986, Journal of virology.
[38] P. Möller,et al. Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gamma. , 1986, Journal of immunology.
[39] H. Burgert,et al. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens , 1985, Cell.
[40] F. Momburg,et al. Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. , 1998, Advances in immunology.
[41] David C. Johnson,et al. Herpesvirus evasion of the immune system. , 1998, Current topics in microbiology and immunology.
[42] U. Koszinowski,et al. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. , 1997, Immunity.
[43] M. Foti,et al. The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. , 1997, Immunity.
[44] P. A. Peterson,et al. Inhibition of MHC class I antigen presentation by viral proteins , 1997, Journal of Molecular Medicine.
[45] C. Watts,et al. Capture and processing of exogenous antigens for presentation on MHC molecules. , 1997, Annual review of immunology.
[46] H. Ploegh,et al. Generation, translocation, and presentation of MHC class I-restricted peptides. , 1995, Annual review of biochemistry.
[47] P. Seglen. Inhibitors of lysosomal function. , 1983, Methods in enzymology.